Monteferrario, D <br/><br/>
High DNA-methyltransferase 3B expression predicts poor outcome in acute myeloid leukemia, especially among patients with co-occurring NPM1 and FLT3 mutations.  [electronic resource] 

 -  Blood cancer journal  Aug 2014 
 - e233 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>2044-5385 
<br/><br/><label>Standard No.: </label>10.1038/bcj.2014.51  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>DNA (Cytosine-5-)-Methyltransferases--biosynthesis<br/>Disease-Free Survival<br/>Female<br/>Gene Expression Regulation, Enzymologic<br/>Gene Expression Regulation, Leukemic<br/>Humans<br/>Leukemia, Myeloid, Acute--enzymology<br/>Male<br/>Middle Aged<br/>Mutation<br/>Nuclear Proteins--genetics<br/>Nucleophosmin<br/>Survival Rate<br/>fms-Like Tyrosine Kinase 3--genetics<br/>DNA Methyltransferase 3B